Autologous Anti-PSMA Gene-Modified T-Lymphocytes

**Semantic type:** Cell|Pharmacologic Substance

**Definition:** Autologous prostate specific membrane antigen (PSMA) gene-modified T lymphocytes with potential antineoplastic activity. Human autologous T-lymphocytes are isolated and transduced ex vivo with a retrovirus encoding a chimeric immune receptor (CIR) consisting of an antibody fragment against PSMA fused with signaling domains of the T cell. Upon reintroduction into the patient, autologous anti-PSMA gene-modified T-cells bind to PSMA-expressing prostate cancer cells, which may result in specific cytotoxic T-lymphocyte (CTL) tumor cell killing.

**Synonyms:** - Autologous Anti-Prostate-Specific Membrane Antigen Gene-Modified T-Cells